References
- Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
- Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2003;17:725–7.
- Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S, et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol. 2002;52:771–8.
- Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reap- praisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci. 2002;193:73–8.
- Vincent AM, Mobley BC, Hiller A, Feldman EL. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis. 2004;16:407–16.
- Vincent AM, Olzmann JA, Brownlee M, Sivitz WI, Russell JW. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes. 2004;53:726–34.
- Sarang SS, Yoshida T, Cadet R, Valeras AS, Jensen RV, Gullans SR. Discovery of molecular mechanisms of neuro- protection using cell-based bioassays and oligonucleotide arrays. Physiol Genomics. 2002;11:45–52.
- Vartiainen N, Keksa-Goldsteine V, Goldsteins G, Koistinaho J. Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia/ reoxygenation damage in culture. J Neurochem. 2002;82:329–35.
- Smith SA, May FJ, Monteith GR, Roberts-Thomson SJ. Activation of the peroxisome proliferator-activated receptor- alpha enhances cell death in cultured cerebellar granule cells. J Neurosci Res. 2001;66:236–41.
- Tikka TM, Vartiainen NE, Goldsteins G, Oja SS, Andersen PM, Marklund SL, et al. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neuron disease. Brain. 2002;125:722–31.
- Kriz J, Gowing G, Julien JP. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann Neurol. 2003;53:429–36.
- Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002;417:74–8.
- Hurko O, Walsh FS. Novel drug development for amyo-trophic lateral sclerosis. J Neurol Sci. 2000;180:21–8.
- Ziegler MG, Brooks BR, Lake CR, Wood JH, Enna SJ. Norepinephrine and gamma-aminobutyric acid in amyo- trophic lateral sclerosis. Neurology. 1980;30:98–101.
- Eisen A, Nakajima M, Weber M. Corticomotoneuronal hyper-excitability in amyotrophic lateral sclerosis. J Neurol Sci. 1998; 160(Suppl 1):S64–8.
- Greffrath W, Kirschstein T, Nawrath H, Treede RD. Acetylsalicylic acid reduces heat responses in rat nociceptive primary sensory neurons: evidence for a new mechanism of action. Neurosci Lett. 2002;320:61–4.
- Vincent AM, Mobley BC, Kim B, Feldman EL. IGF-I signaling mechanisms in a cell culture model of ALS. Growth Horm IGF Res. 2002;12:253.
- Leist M, Volbracht C, Kuhnle S, Fava E, Ferrando-May E, Nicotera P. Caspase-mediated apoptosis in neuronal exci- totoxicity triggered by nitric oxide. Mol Med. 1997;3:750–64.
- Mattson MP. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med. 2003;3:65–94.
- Toyoda T, Kassell NF, Lee KS. Induction of ischemic tolerance and antioxidant activity by brief focal ischemia. Neuroreport. 1997;8:847–51.